GlassScriptPhysician profile
Candice K Smith
NPI 1811184088
$890.46
in general payments reported to CMS, 2019-2025
19 companies · $50.65 in 2025
The $50.65 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.24 · 2020: $70.63 · 2021: $191 · 2022: $73.01 · 2023: $153 · 2024: $322 · 2025: $50.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $165.03 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $99.61 | 2020-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $90.21 | 2024 | |
| Sanofi-Aventis U.S. LLC | $56.42 | 2024-2025 | |
| Cranial Technologies, INC | $55.44 | 2021-2025 | Doc Band |
| Sobi, INC | $50.95 | 2023 | |
| Pfizer INC. | $47.14 | 2020-2024 | |
| Seqirus USA INC | $46.43 | 2021-2024 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $45.30 | 2021-2023 | Flumist Quadrivalent |
| Tris Pharma INC | $38.28 | 2021 | |
| Genentech USA, INC. | $33.58 | 2019-2021 | |
| Ascendis Pharma Endocrinology INC | $26.77 | 2022 | |
| Phadia US INC. | $24.18 | 2021 | |
| Abbvie INC. | $19.83 | 2022 | |
| Dynavax Technologies Corporation | $19.58 | 2024 | Heplisav-B |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valneva USA, INC. | $19.56 | 2024 | |
| Sanofi Pasteur INC. | $17.72 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.71 | 2025 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.72 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.